Search results
FDA Head Questioned on Zantac’s Hidden Cancer Risk by Top Democrat DeLauro
Bloomberg via Yahoo News· 1 year ago(Bloomberg) -- The Food and Drug Administration’s chief is facing questions from a top lawmaker...
First it was blood pressure medication. Now FDA eyes more drugs for cancer-causing chemical.
USA TODAY via Yahoo News· 1 year agoFor people managing high blood pressure, recalls of the carcinogen-tainted drug quinapril might...
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
Investor's Business Daily· 2 years agoPharmaceutical stocks GSK, Sanofi and Haleon have wiped out a combined $31 billion in market cap...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 1 week agoMonday saw a 9% drop in GlaxoSmithKline’s (GSK) share price on the London Stock Exchange (LSE), following a Delaware judge’s ruling on 31 May that more...
FTSE 100: GSK loses £4.5bn in value on Zantac lawsuit concerns
Yahoo Finance UK· 2 years agoGSK lost billions in value amid litigation concerns over the heartburn drug Zantac. Photo: Drew...
GSK & Others Get Relief as US Court Dismisses Zantac Litigation
Zacks via Yahoo Finance· 2 years agoGSK GSK issued a statement welcoming the decision of a Multi-District Litigation (MDL) court of...
GSK's Relief For Few Months, First Trial Claiming Zantac Caused Cancer Pushed Into Late 2023
Benzinga via Yahoo Finance· 1 year agoThe first scheduled trial expected next week, related to GSK Plc's (NYSE: GSK) Zantac associated...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 2 weeks ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
Scientists Are Finding Out Just How Toxic Your Stuff Is
Time via Yahoo News· 1 month agoA Valisure researcher works in the New Haven–based lab. Credit - Adrienne Grunwald for TIME If you...
GSK Shares Inch Higher After Slumping on Heartburn Drug Litigation Worries
Investing.com via Yahoo Finance· 2 years agoBy Scott Kanowsky Investing.com -- Shares in GSK plc (LON:GSK) rose on Friday, paring back some heavy recent losses, as the British pharmaceutical giant responded to a bout of speculation around ...